Molecular assessment and the current limits of post-transplant prognostication for chronic myelomonocytic leukemia
Christopher J Gibson1, John Koreth1
1Division of Hematologic Malignancies, Dana-Farber Cancer Institute 450 Brookline Ave., Boston MA 02215.
Haematologica
|April 21, 2022
Abstract
No abstract available in PubMed .
More Related Videos
09:01Flow Cytometry to Estimate Leukemia Stem Cells in Primary Acute Myeloid Leukemia and in Patient-derived-xenografts, at Diagnosis and Follow Up
Published on: March 26, 2018
14.2K
07:38Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants
Published on: June 6, 2025
292
